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Background: Vesicourethral anastomotic stricture (VAS) is a rare but serious complication following radical
prostatectomy (RP), and various types of managements for VAS have been proposed. We investigated the efficacy
of transurethral balloon dilation in the management of VAS after RP.
Methods: A total of 128 consecutive patients underwent open RP at our hospital between 2008 and 2013; of these,
10 patients (7.8 %) developed VAS. Transurethral balloon dilation was performed in all 10 patients, using a high
pressure balloon catheter under fluoroscopic and endoscopic guidance. Follow-up endoscopy was performed, and
patients in whom the stricture had recurred underwent repeat dilation. We retrospectively evaluated the
management of VAS and short-term efficacy of high pressure balloon dilation.
Results: The mean time from RP to diagnosis of VAS was 9 months (2–40 months); eight patients (80 %) were
diagnosed within 6 months of RP. Balloon dilation of VAS was technically successful in all patients, and no
perioperative complications were recorded. The median follow-up after balloon dilation was 24 months (7–67
months). There was no recurrence of VAS in eight patients (80 %) after the first balloon dilation, and all patients
were controlled within the twice.
Conclusion: High pressure balloon dilation is a highly effective and minimally invasive procedure for treating VAS.
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Vesicourethral anastomotic stricture (VAS) is one of the
most common complications after radical prostatectomy
(RP), with rates ranging from 0.48-32 % [1, 2]. The devel-
opment of a VAS can cause severe voiding dysfunction
and result in significant deterioration of the patients’ qual-
ity of life.
Factors predisposed to the development of a VAS are
not well understood, but they are reported to be re-
lated to prior transurethral resection of the prostate
(TURP), the oncologic outcome, excessive blood loss,
anastomotic ischemia, or urinary extravasation at the
site of the VAS [3, 4]. Surgical techniques, including
the suturing procedure and choice of bladder neck* Correspondence: ishiigen@gmail.com
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considered important factors [5].
There are various methods for managing a VAS, in-
cluding simple or balloon dilation; cold knife incision,
electrocautery incision or resection, and laser treat-
ment. Among these options, cold knife incision is one
of the most commonly used techniques, although opti-
mal treatment remains controversial. While balloon
dilation has also been used for managing VAS, previous
studies have indicated that the outcomes of balloon
dilation were poor, compared to those of alternative
treatment modalities [6, 7]. We used the X Force® U30
balloon dilation catheter (Bard Medical Division), which
can inflate up to 30 standard atmosphere (ATM). It
provides sufficient dilation against even a severe VAS
compared to conventional catheters. Therefore in this
study, we assessed the efficacy of performing highle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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Fig. 1 a a pinhole vesicourethral anastomotic stricture. b Endoscopic
findings of the vesicourethral anastomotic stricture after successful
balloon dilation
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following RP.
Methods
The study was approved by Atsugi City Hospital’s re-
view board, and written informed consent was ob-
tained from all patients. Data from 128 consecutive
patients who had undergone open RP for clinically lo-
calized prostate cancer were enrolled between 2008
and 2013. Patients who complained of voiding difficul-
ties (n = 10, 7.8 %) subsequently developed a VAS, and
the presence of which was confirmed endoscopically
in all cases (Fig. 1). All patients were treated with
transurethral balloon dilation for VAS.
At the time of open RP, bladder reconstruction and
eversion of the bladder mucosa had been performed
as routine techniques, and vesicourethral anastomosis
was performed using four interrupted sutures. De-
scriptive characteristics of the study population are
shown in Table 1. In two cases, TURP was performed
prior to RP. The median blood loss during RP was
1,387 mL, and five patients (50 %) had excessive
bleeding (>1.5 L). Prolonged urinary leakage at the site
of anastomosis occurred in 1 case. All the patients
could void with a decent stream at the time of ureth-
ral catheter removal. None of the patients had sus-
pected local recurrence of prostate cancer, but two
who had extra prostatic extension (EPE) with resec-
tion margin (RM) received adjuvant radiotherapy for
the prostate region.
Transurethral balloon dilation was performed under
regional anesthesia. We used a high pressure balloon
catheter, the X Force®, which consists of a 6-French (Fr)
open lumen, blunt-tip catheter, and 6-cm long balloon
that inflates fully to 30 Fr at a maximum inflation pres-
sure of 30 ATM. A 10-mL Eagle inflation device was also
used.
After confirming the presence of VAS via endoscopy, a
guide wire was inserted beyond the stricture under
fluoroscopic guidance. The guide wire was inserted into
the bladder before the dilation catheter was advanced
over the guide wire into the bladder. The dilation cath-
eter was positioned in the middle of the VAS, overlap-
ping the normal urethra and likely including the
external urethral sphincter. The balloon was inflated to
30 ATM pressure for 5 minutes, using pure contrast
medium so that dilation of the VAS could be visualized
(Fig. 2). Balloon dilation was performed three times
with an interval period of 1 minute. After the proced-
ure, a transurethral 16-Fr Foley catheter was placed
until the following day.
Follow-up was performed via endoscopy. In patients
with recurrent stricture, a second dilation procedure was
performed. Recurrence of the stricture and the incidenceof complications, particularly incontinence, were evalu-
ated retrospectively.
Results
The mean time from RP to the diagnosis of VAS was
9 months (range, 2–40 months) (Table 2), and eight pa-
tients (80 %) were diagnosed within 6 months after RP.
Balloon dilation of VAS was technically successful in all
patients, and no perioperative complications were re-
corded. All the patients were able to void spontan-
eously after the transurethral catheter was removed.
(a)
(b)
Fig. 2 a Fluoroscopic image demonstrates the concentric deformity
in the balloon at the site of the vesicourethral anastomotic stricture.
b No deformity is noted in the balloon after dilation with high
pressure inflation
Table 1 Demographic characters of patients with vesicourethral
strictures (VAS) after radical prostatectomy (RP)
No. of Patient 10








Blood loss at the time of RP (median) 1387 (775–3780)
Adjuvant radiotherapy 2
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trolled by only using a safety pad in all patients, but
one patient complained about having to use more than
one pads. The median follow-up after balloon dilation
was 24 months (7–67 months). Eight patients (80 %)
were successfully treated, without recurrence, following
the first balloon dilation procedure. In the remaining 2
patients, recurrence of the stricture necessitated a re-
peat balloon dilation procedure, which was performed
within 6 months of the initial dilation. No patient
required > 2 balloon dilations.
Discussion
Worldwide, open RP is performed as a standard pro-
cedure for organ-confined prostate cancer. VAS is one
of the most common complications after open RP, al-
though rates of VAS development vary widely [1, 2].
Occasionally, VAS can be associated with severe void-
ing dysfunction, and consequently a deterioration in
quality of life. In both laparoscopic and robotic assisted
laparoscopic RP, there are lower incidences of VAS, in
the ranging from 0–3 % [8–10]. While there is no de-
finitive cause of VAS, it has been suggested that the su-
turing technique is the most important preventative
aspect [10].
Numerous approaches are available for the man-
aging VAS, and much has been published on the
various procedures (Table 3). Simple dilation using
catheters or bougies is often performed as the initial
treatment modality; however, this is associated with
high recurrence rates. Cold knife incision is the
most commonly performed invasive procedure, with
high success rates [7, 11]. More recently, new mo-
dalities using bipolar electrocautery or the holmium
YAG laser have been reported with acceptable effi-
cacies [12, 13].Transurethral balloon dilation is an established
method of treatment for urethral stricture. The radial
application of forces dilates the stricture, while avoiding









Recurrence at the time of
the last follow up
No. of pad (/day)
pre dilation
No. of pads (/day)
post dilation
1 6 1 5 67 - 1 5
2 6 1 3 53 - 0 0
3 3 - - 31 - 0 0
4 3 - - 31 - 0 0
5 3 - - 27 - 1 1
6 4 - - 20 - 1 1
7 40 - - 16 - 1 1
8 4 - - 14 - 1 1
9 2 - - 22 - 0 0
10 22 - - 7 - 0 0
Ishii et al. BMC Urology  (2015) 15:62 Page 4 of 5the potentially traumatic shearing forces associated
with sequential rigid dilation. Although transurethral
balloon dilation has been performed for VAS previ-
ously, there are limited data regarding the outcomes
in comparison to other modalities. Ramchandani et al.
reported a recurrence rate of 41 %. In their series, the
balloon of the dilation catheter did not expand com-
pletely [6].
We used a new urethral balloon catheter that
achieves sufficient dilation against a more severe
VAS using high pressure of up to 30 ATM. However,
it is unclear whether a higher pressure of balloon
dilation is more effective than conventional balloon
dilation.
In the present study, balloon dilation was associated
with a high success rate (80 %), and recurrent strictures
could be controlled by performing repeated balloon
dilation. However no patients required further treat-
ment. Such findings are comparable to those associated
with cold knife incision, which is considered the stand-
ard management for VAS.
Transurethral balloon dilation is simpler and less
invasive than cold knife incision. Balloon dilation also
has the advantage of a lower risk of urethral vascularTable 3 Managing vesicourethral anastomotic strictures (VAS) follow
management
Giannarini et al., [7] Cold knife incision
Popken et al., [14] Electricautery resection
Brodak et al., [12] Bipolar resection
Lagerveld et al., [13] Holmium YAG laser
Ramchandani et al., [6] Conventional balloon dilation
Present study High pressure balloon dilationinjury. There is a wide range of complications associ-
ated with cold knife incision. Perineal hematoma and
urethral hemorrhage are the most common complica-
tions ranging up to 20 % [15], and also de novo in-
continence as a result of VAS has an incidence of
75 % [7].
However, no complications were reported in our study,
except for worsened urinary incontinence in one patient
(10 %).
Although our study was limited by the small number
of patients and relatively short follow-up duration,
dilation using this new high pressure balloon catheter
appears to be an effective and minimally invasive treat-
ment for VAS.Conclusion
Although balloon dilation for VAS has been performed
previously, it was believed to have a low efficacy. We
demonstrated excellent short-term results by using this
new catheter, which can be inflated to a higher pressure
than standard balloon catheters. High pressure balloon
dilation appears to be a viable option for the managing
VAS secondary to RP.ing radical prostatectomy reported in the literature
cases Recurrence rate Follow up (month)
43 26.0 % 12
15 53.3 % 12-72
22 9.0 % 14-72
10 0 % 3-29
27 41.0 % 1-84
10 20.0 % 7-67
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